These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 29477974)
1. Does the CHA Rovaris G; Solimene F; D'Onofrio A; Zanotto G; Ricci RP; Mazzella T; Iacopino S; Della Bella P; Maglia G; Senatore G; Quartieri F; Biffi M; Curnis A; Calvi V; Rapacciuolo A; Santamaria M; Capucci A; Giammaria M; Campana A; Caravati F; Giacopelli D; Gargaro A; Pisanò EC Heart Rhythm; 2018 Jul; 15(7):971-979. PubMed ID: 29477974 [TBL] [Abstract][Full Text] [Related]
2. Device-detected atrial sensing amplitudes as a marker of increased risk for new onset and progression of atrial high-rate episodes. Biffi M; Celentano E; Giammaria M; Curnis A; Rovaris G; Ziacchi M; Miracapillo G; Saporito D; Baroni M; Quartieri F; Marini M; Pepi P; Senatore G; Caravati F; Calvi V; Tomasi L; Nigro G; Bontempi L; Notarangelo F; Santobuono VE; Boggian G; Arena G; Solimene F; Giaccardi M; Maglia G; Perini AP; Volpicelli M; Giacopelli D; Gargaro A; Iacopino S Heart Rhythm; 2024 Sep; 21(9):1630-1639. PubMed ID: 38493989 [TBL] [Abstract][Full Text] [Related]
3. Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation: The West Birmingham Atrial Fibrillation Project. Li YG; Miyazawa K; Pastori D; Szekely O; Shahid F; Lip GYH Int J Cardiol; 2019 Oct; 292():126-130. PubMed ID: 31031080 [TBL] [Abstract][Full Text] [Related]
4. Duration of atrial high-rate episodes and CHA Chen JY; Lu WD J Cardiol; 2021 Feb; 77(2):166-173. PubMed ID: 32873414 [TBL] [Abstract][Full Text] [Related]
5. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation. Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study. Saliba W; Gronich N; Barnett-Griness O; Rennert G Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854 [TBL] [Abstract][Full Text] [Related]
7. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126 [TBL] [Abstract][Full Text] [Related]
8. CHA Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228 [TBL] [Abstract][Full Text] [Related]
9. Value of ATRIA stroke risk score in predicting atrial high-rate episodes: A comparison of six different risk scores. Artac I; Karakayali M; Omar T; Hamideyin S; Karabag Y; Ilis D; Rencuzogullari I Pacing Clin Electrophysiol; 2023 Aug; 46(8):978-985. PubMed ID: 37283495 [TBL] [Abstract][Full Text] [Related]
10. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation. Wakula P; Neumann B; Kienemund J; Thon-Gutschi E; Stojakovic T; Manninger M; Scherr D; Scharnagl H; Kapl M; Pieske B; Heinzel FR Europace; 2017 Apr; 19(4):544-551. PubMed ID: 28431065 [TBL] [Abstract][Full Text] [Related]
11. CHA Hu WS; Lin CL Int J Cardiol; 2017 May; 235():56-60. PubMed ID: 28262350 [TBL] [Abstract][Full Text] [Related]
12. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. Saliba W; Rennert G Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101 [TBL] [Abstract][Full Text] [Related]
13. Atrial high rate episodes in patients with cardiac implantable electronic devices: implications for clinical outcomes. Miyazawa K; Pastori D; Li YG; Székely O; Shahid F; Boriani G; Lip GYH Clin Res Cardiol; 2019 Sep; 108(9):1034-1041. PubMed ID: 30759274 [TBL] [Abstract][Full Text] [Related]
14. Comparison of CHA Hu WS; Lin CL Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919 [TBL] [Abstract][Full Text] [Related]
15. Role of CHA Hu WS; Lin CL BMJ Open; 2018 Mar; 8(3):e020065. PubMed ID: 29567851 [TBL] [Abstract][Full Text] [Related]
16. The performance of five models compared with atrial high rate episodes predicts new atrial fibrillation after cardiac implantable electronic devices implantation. Chen JY; Chen TW; Lu WD Ann Noninvasive Electrocardiol; 2022 Sep; 27(5):e12978. PubMed ID: 35665984 [TBL] [Abstract][Full Text] [Related]
17. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Hu WS; Lin CL Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109 [TBL] [Abstract][Full Text] [Related]
18. Competitive interaction between chronic obstructive pulmonary disease and CHA Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184 [TBL] [Abstract][Full Text] [Related]
19. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809 [TBL] [Abstract][Full Text] [Related]
20. Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation. Imberti JF; Bonini N; Tosetti A; Mei DA; Gerra L; Malavasi VL; Mazza A; Lip GYH; Boriani G Biology (Basel); 2022 Mar; 11(3):. PubMed ID: 35336817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]